133 related articles for article (PubMed ID: 35405317)
1. Transcription Factor FOXO3a Overexpression Inhibits the Progression of Neuroblastoma by Regulating the miR-21/SPRY2/ERK Axis.
Chen J; Xu Y; Wu P; Chen X; Weng W; Li D
World Neurosurg; 2022 Aug; 164():e99-e112. PubMed ID: 35405317
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2.
Li J; Yang R; Dong Y; Chen M; Wang Y; Wang G
J Exp Clin Cancer Res; 2019 Jan; 38(1):38. PubMed ID: 30691517
[TBL] [Abstract][Full Text] [Related]
3. MiR-592 Promotes Gastric Cancer Proliferation, Migration, and Invasion Through the PI3K/AKT and MAPK/ERK Signaling Pathways by Targeting Spry2.
He Y; Ge Y; Jiang M; Zhou J; Luo D; Fan H; Shi L; Lin L; Yang L
Cell Physiol Biochem; 2018; 47(4):1465-1481. PubMed ID: 29949784
[TBL] [Abstract][Full Text] [Related]
4. Foxo3a-mediated overexpression of microRNA-622 suppresses tumor metastasis by repressing hypoxia-inducible factor-1α in ERK-responsive lung cancer.
Cheng CW; Chen PM; Hsieh YH; Weng CC; Chang CW; Yao CC; Hu LY; Wu PE; Shen CY
Oncotarget; 2015 Dec; 6(42):44222-38. PubMed ID: 26528854
[TBL] [Abstract][Full Text] [Related]
5. SPROUTY2 is a β-catenin and FOXO3a target gene indicative of poor prognosis in colon cancer.
Ordóñez-Morán P; Irmisch A; Barbáchano A; Chicote I; Tenbaum S; Landolfi S; Tabernero J; Huelsken J; Muñoz A; Pálmer HG
Oncogene; 2014 Apr; 33(15):1975-85. PubMed ID: 23624922
[TBL] [Abstract][Full Text] [Related]
6. Crocin suppresses breast cancer cell proliferation by down-regulating tumor promoter miR-122-5p and up-regulating tumor suppressors FOXP2 and SPRY2.
Jia Y; Yang H; Yu J; Li Z; Jia G; Ding B; Lv C
Environ Toxicol; 2023 Jul; 38(7):1597-1608. PubMed ID: 36988377
[TBL] [Abstract][Full Text] [Related]
7. ING4 suppresses hepatocellular carcinoma via a NF-κB/miR-155/FOXO3a signaling axis.
Qian F; Hu Q; Tian Y; Wu J; Li D; Tao M; Qin L; Shen B; Xie Y
Int J Biol Sci; 2019; 15(2):369-385. PubMed ID: 30745827
[TBL] [Abstract][Full Text] [Related]
8. Hsa-miR-22-3p inhibits liver cancer cell EMT and cell migration/ invasion by indirectly regulating SPRY2.
Cui S; Chen Y; Guo Y; Wang X; Chen D
PLoS One; 2023; 18(2):e0281536. PubMed ID: 36749775
[TBL] [Abstract][Full Text] [Related]
9. MiR-223 regulates CDDP resistance in pancreatic cancer via targeting FoxO3a.
Huang R; Song X; Wang CM
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7892-7898. PubMed ID: 31599414
[TBL] [Abstract][Full Text] [Related]
10. Effects of miR-155 on proliferation and apoptosis by regulating FoxO3a/BIM in liver cancer cell line HCCLM3.
Liao WW; Zhang C; Liu FR; Wang WJ
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1277-1285. PubMed ID: 29565484
[TBL] [Abstract][Full Text] [Related]
11. miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a.
Cao MQ; You AB; Zhu XD; Zhang W; Zhang YY; Zhang SZ; Zhang KW; Cai H; Shi WK; Li XL; Li KS; Gao DM; Ma DN; Ye BG; Wang CH; Qin CD; Sun HC; Zhang T; Tang ZY
J Hematol Oncol; 2018 Jan; 11(1):12. PubMed ID: 29361949
[TBL] [Abstract][Full Text] [Related]
12. Effects of miR-223 on colorectal cancer cell proliferation and apoptosis through regulating FoxO3a/BIM.
Ju H; Tan JY; Cao B; Song MQ; Tian ZB
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3771-3778. PubMed ID: 29949152
[TBL] [Abstract][Full Text] [Related]
13. LncRNA RMRP silence curbs neonatal neuroblastoma progression by regulating microRNA-206/tachykinin-1 receptor axis via inactivating extracellular signal-regulated kinases.
Pan J; Zhang D; Zhang J; Qin P; Wang J
Cancer Biol Ther; 2019; 20(5):653-665. PubMed ID: 30582709
[TBL] [Abstract][Full Text] [Related]
14. microRNA-9 targets matrix metalloproteinase 14 to inhibit invasion, metastasis, and angiogenesis of neuroblastoma cells.
Zhang H; Qi M; Li S; Qi T; Mei H; Huang K; Zheng L; Tong Q
Mol Cancer Ther; 2012 Jul; 11(7):1454-66. PubMed ID: 22564723
[TBL] [Abstract][Full Text] [Related]
15. MiR-155 targeting FoxO3a regulates oral cancer cell proliferation, apoptosis, and DDP resistance through targeting FoxO3a.
Li X; Liu K; Zhou W; Jiang Z
Cancer Biomark; 2020; 27(1):105-111. PubMed ID: 31771044
[TBL] [Abstract][Full Text] [Related]
16. Targeted Regulation of FoxO3a by miR-372 to Mediate Gastric Carcinoma Cell Apoptosis and DDP Drug Resistance.
Wang C; Wang C; Qiu C; Su Z
Cancer Biother Radiopharm; 2020 Dec; 35(10):753-759. PubMed ID: 32379491
[No Abstract] [Full Text] [Related]
17. Downregulation of microRNA-182-5p contributes to renal cell carcinoma proliferation via activating the AKT/FOXO3a signaling pathway.
Xu X; Wu J; Li S; Hu Z; Xu X; Zhu Y; Liang Z; Wang X; Lin Y; Mao Y; Chen H; Luo J; Liu B; Zheng X; Xie L
Mol Cancer; 2014 May; 13():109. PubMed ID: 24886554
[TBL] [Abstract][Full Text] [Related]
18. Pro-carcinogenic actions of miR-155/FOXO3a in colorectal cancer development.
Wang D; Geng W; Han L; Song R; Qu Q; Chen X; Luo X
Cell Mol Biol (Noisy-le-grand); 2023 Oct; 69(10):160-165. PubMed ID: 37953568
[TBL] [Abstract][Full Text] [Related]
19. Silencing of long chain noncoding RNA paternally expressed gene (PEG10) inhibits the progression of neuroblastoma by regulating microRNA-449a (miR-449a)/ribosomal protein S2 (RPS2) axis.
Zhang J; Liu W; Ji P; Zhang Y
Bioengineered; 2022 Mar; 13(3):6309-6322. PubMed ID: 35212607
[TBL] [Abstract][Full Text] [Related]
20. Aldose reductase inhibition prevents colon cancer growth by restoring phosphatase and tensin homolog through modulation of miR-21 and FOXO3a.
Saxena A; Tammali R; Ramana KV; Srivastava SK
Antioxid Redox Signal; 2013 Apr; 18(11):1249-62. PubMed ID: 22978663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]